Lista de obras - Ana Fortuño - Dominio Público Uruguay

A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

artículo científico publicado en 2007

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

artículo científico publicado en 2013

Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.

artículo científico publicado en 2003

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

artículo científico publicado en 2004

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

artículo científico publicado en 2012

Connection Between the Early Phases of Kidney Disease and the Metabolic Syndrome

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

artículo científico publicado en 2013

Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.

artículo científico publicado en 2004

HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.

artículo científico publicado en 2011

Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells

artículo científico publicado en 2009

Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men.

artículo científico publicado en 2017

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

artículo científico publicado en 2005

Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients

artículo científico publicado en 2009

Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages

artículo científico publicado en 2009

Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.

artículo científico publicado en 2010

Leptin Induces Oxidative Stress Through Activation of NADPH Oxidase in Renal Tubular Cells: Antioxidant Effect of L-Carnitine.

artículo científico publicado en 2016

Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta

artículo científico publicado en 2002

Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms

artículo científico publicado en 2010

Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension

artículo científico publicado en 2009

Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK.

artículo científico publicado en 2016

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

artículo científico publicado en 2017

Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways

artículo científico publicado en 2013

Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling

artículo científico publicado en 2008

NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases

artículo científico publicado en 2008

NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

artículo científico publicado en 2005

NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension

artículo científico publicado en 2005

Oxidative stress and atherosclerosis in early chronic kidney disease

artículo científico publicado en 2006

Oxidative stress and vascular remodelling.

artículo científico publicado en 2005

Oxidative stress in hypertension: from the SNPs to the clinical phenotype

artículo científico publicado en 2004

Oxidative stress, endothelial dysfunction and cerebrovascular disease

artículo científico publicado en 2007

Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.

artículo científico publicado en 2012

Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice

artículo científico publicado en 2003

Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome

Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9

artículo científico publicado en 2006

Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome

artículo científico publicado en 2006

Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models

artículo científico publicado en 1997

Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

artículo científico publicado en 2010

Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate

article published in 1997

Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.

artículo científico publicado en 1997

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension

artículo científico publicado en 2006

The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism

scientific article published on 12 October 2006

The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.

artículo científico publicado en 2009

The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

artículo científico

The senescence-accelerated mouse prone-8 (SAM-P8) oxidative stress is associated with upregulation of renal NADPH oxidase system

artículo científico publicado en 2013

Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis

artículo científico publicado en 2015

Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension

artículo científico publicado en 2012

Vasodilator effect of ghrelin in the rat aorta

artículo científico publicado en 2008

[Connection between the early phases of kidney disease and the metabolic syndrome]

scientific article published on 09 April 2011

l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-κB translocation to the nucleus.

artículo científico publicado en 2017

¿El síndrome metabólico en España necesita más estudios descriptivos o más evidencia de su implicación en prevención secundaria? Respuesta

article

Lista de obras de Ana Fortuño

A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

Connection Between the Early Phases of Kidney Disease and the Metabolic Syndrome

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.

HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.

Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells

Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men.

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients

Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages

Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.

Leptin Induces Oxidative Stress Through Activation of NADPH Oxidase in Renal Tubular Cells: Antioxidant Effect of L-Carnitine.

Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta

Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms

Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension

Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK.

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways

Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling

NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases

NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension

Oxidative stress and atherosclerosis in early chronic kidney disease

Oxidative stress and vascular remodelling.

Oxidative stress in hypertension: from the SNPs to the clinical phenotype

Oxidative stress, endothelial dysfunction and cerebrovascular disease

Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.

Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice

Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome

Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9

Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome

Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models

Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate

Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension

The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism

The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.

The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

The senescence-accelerated mouse prone-8 (SAM-P8) oxidative stress is associated with upregulation of renal NADPH oxidase system

Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis

Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension

Vasodilator effect of ghrelin in the rat aorta

[Connection between the early phases of kidney disease and the metabolic syndrome]

l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-κB translocation to the nucleus.

¿El síndrome metabólico en España necesita más estudios descriptivos o más evidencia de su implicación en prevención secundaria? Respuesta